Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is set to hold a Board meeting on August 19, 2024, where they will discuss and potentially approve the interim financial results for the first half of the year. This meeting will cover the performance of the company and its subsidiaries up to June 30, 2024. The announcement was made by the company’s Chairman, LIU Gexin, and includes a current list of board members.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.